← Open Payments lookup

NPI 1689172389: Open Payments

NPI 1689172389. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$133 in 7 payments from 5 companies in 2025. Trend: 2023 $497 · 2024 $834 · 2025 $133

Food & beverage: $133
CompanyPaymentsAmount
Lilly USA, LLC2$39
GlaxoSmithKline, LLC.2$28
Phathom Pharmaceuticals, Inc.1$28
PFIZER INC.1$21
ABBVIE INC.1$18

Products named: TRELEGY ELLIPTA, VOQUEZNA, PAXLOVID, JARDIANCE, MOUNJARO, VRAYLAR.